blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2121746

EP2121746 - POTENT AND SELECTIVE MEDIATORS OF CHOLESTEROL EFFLUX [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.09.2012
Database last updated on 05.10.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[N/P]
Former [2009/48]For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607-5200 / US
Inventor(s)01 / BIELICKI, John K.
1008 Lakeridge Place
San Ramon, CA 94582-4817 / US
02 / JOHANSSON, Jan
165 Merano Street
Danville, California 94526 / US
 [2009/48]
Representative(s)Campbell, Patrick John Henry
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2011/46]Campbell, Patrick John Henry
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Former [2009/48]Campbell, Patrick John Henry
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date07874411.713.12.2007
[2009/48]
WO2007US87477
Priority number, dateUS20060874909P13.12.2006         Original published format: US 874909 P
[2009/48]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008115303
Date:25.09.2008
Language:EN
[2008/39]
Type: A2 Application without search report 
No.:EP2121746
Date:25.11.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 25.09.2008 takes the place of the publication of the European patent application.
[2009/48]
Type: B1 Patent specification 
No.:EP2121746
Date:16.11.2011
Language:EN
[2011/46]
Search report(s)International search report - published on:EP24.12.2008
ClassificationIPC:C07K14/705
[2009/48]
CPC:
C07K14/775 (EP,US); A61P29/00 (EP); A61P3/06 (EP);
A61P39/02 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07K14/4703 (EP,US); A61K38/00 (EP,US); A61K38/16 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/48]
TitleGerman:POTENTE UND SELEKTIVE MITTLERSUBSTANZEN VON CHOLESTEROLEFFLUX[2009/48]
English:POTENT AND SELECTIVE MEDIATORS OF CHOLESTEROL EFFLUX[2009/48]
French:MÉDIATEURS PUISSANTS ET SÉLECTIFS D'EFFLUX DE CHOLESTÉROL[2009/48]
Entry into regional phase10.07.2009National basic fee paid 
10.07.2009Designation fee(s) paid 
10.07.2009Examination fee paid 
Examination procedure10.07.2009Examination requested  [2009/48]
28.09.2009Amendment by applicant (claims and/or description)
09.12.2009Despatch of a communication from the examining division (Time limit: M06)
18.06.2010Reply to a communication from the examining division
28.10.2010Despatch of a communication from the examining division (Time limit: M04)
02.03.2011Reply to a communication from the examining division
09.05.2011Communication of intention to grant the patent
01.09.2011Fee for grant paid
01.09.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.12.2009
Opposition(s)17.08.2012No opposition filed within time limit [2012/43]
Fees paidRenewal fee
28.12.2009Renewal fee patent year 03
27.12.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY16.11.2011
CZ16.11.2011
EE16.11.2011
HU16.11.2011
LT16.11.2011
LV16.11.2011
MT16.11.2011
PL16.11.2011
RO16.11.2011
SI16.11.2011
SK16.11.2011
TR16.11.2011
LU13.12.2011
MC31.12.2011
BG16.02.2012
GR17.02.2012
IS16.03.2012
PT16.03.2012
[2013/45]
Former [2013/44]CY16.11.2011
CZ16.11.2011
EE16.11.2011
LT16.11.2011
LV16.11.2011
MT16.11.2011
PL16.11.2011
RO16.11.2011
SI16.11.2011
SK16.11.2011
TR16.11.2011
LU13.12.2011
MC31.12.2011
BG16.02.2012
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2013/25]CY16.11.2011
CZ16.11.2011
EE16.11.2011
LT16.11.2011
LV16.11.2011
MT16.11.2011
PL16.11.2011
RO16.11.2011
SI16.11.2011
SK16.11.2011
LU13.12.2011
MC31.12.2011
BG16.02.2012
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2013/14]CY16.11.2011
CZ16.11.2011
EE16.11.2011
LT16.11.2011
LV16.11.2011
MT16.11.2011
PL16.11.2011
RO16.11.2011
SI16.11.2011
SK16.11.2011
MC31.12.2011
BG16.02.2012
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/36]CY16.11.2011
CZ16.11.2011
EE16.11.2011
LT16.11.2011
LV16.11.2011
PL16.11.2011
RO16.11.2011
SI16.11.2011
SK16.11.2011
MC31.12.2011
BG16.02.2012
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/35]CY16.11.2011
CZ16.11.2011
EE16.11.2011
LT16.11.2011
LV16.11.2011
PL16.11.2011
SI16.11.2011
MC31.12.2011
BG16.02.2012
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/34]CY16.11.2011
CZ16.11.2011
LT16.11.2011
LV16.11.2011
PL16.11.2011
SI16.11.2011
MC31.12.2011
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/28]CY16.11.2011
LT16.11.2011
LV16.11.2011
PL16.11.2011
SI16.11.2011
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/26]LT16.11.2011
LV16.11.2011
PL16.11.2011
SI16.11.2011
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/24]LT16.11.2011
LV16.11.2011
SI16.11.2011
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/23]LT16.11.2011
GR17.02.2012
IS16.03.2012
PT16.03.2012
Former [2012/21]LT16.11.2011
IS16.03.2012
Former [2012/20]LT16.11.2011
Cited inInternational search[Y]WO2005058938  (UNIV CALIFORNIA [US], et al) [Y] 1-45,56-90 * page 65, paragraph 223; claim 1 *;
 [X]WO2006020040  (TUFTS COLLEGE [US], et al) [X] 46-55,91-103 * page 3, lines 18,19; claim 5 * * page 16, lines 13,14; claims 12,17,31 *;
 [X]  - RAMPRASAD M P ET AL, "Sustained-delivery of an apolipoproteinE-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20020219), vol. 79, no. 1-3, ISSN 0168-3659, pages 207 - 218, XP004340926 [X] 46,49,52,53,55,94-100 * abstract *

DOI:   http://dx.doi.org/10.1016/S0168-3659(01)00552-1
 [Y]  - SPARROW J T ET AL, "Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus.", BIOCHEMISTRY 4 FEB 1992, (19920204), vol. 31, no. 4, ISSN 0006-2960, pages 1065 - 1068, XP002501478 [Y] 1-45,56-90 * abstract *

DOI:   http://dx.doi.org/10.1021/bi00119a015
 [Y]  - SONG Y M ET AL, "Effects of l- or d-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic alpha-helical model peptide on structure and cell selectivity", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20040206), vol. 314, no. 2, ISSN 0006-291X, pages 615 - 621, XP004485007 [Y] 1-45,56-82 * abstract * * page 615, column RIGHT, lines 11-13 *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2003.12.142
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.